The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCELERON PHARMA INC | COM | 00434H108 | 41,133 | 1,553,937 | SH | SOLE | 1,553,937 | 0 | 0 | ||
| AKEBIA THERAPEUTICS INC | COM | 00972D105 | 11,705 | 1,272,247 | SH | SOLE | 1,272,247 | 0 | 0 | ||
| ANAPTYSBIO INC | COM | 032724106 | 84,180 | 3,033,504 | SH | SOLE | 3,033,504 | 0 | 0 | ||
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 18,241 | 1,456,972 | SH | SOLE | 1,456,972 | 0 | 0 | ||
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | 66,963 | 3,224,046 | SH | SOLE | 3,224,046 | 0 | 0 | ||
| CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 4,862 | 223,317 | SH | SOLE | 223,317 | 0 | 0 | ||
| DERMIRA INC | COM | 24983L104 | 25,522 | 748,240 | SH | SOLE | 748,240 | 0 | 0 | ||
| FLEXION THERAPEUTICS INC | COM | 33938J106 | 37,613 | 1,397,718 | SH | SOLE | 1,397,718 | 0 | 0 | ||
| HTG MOLECULAR DIAGNOSTICS INC | COM | 40434H104 | 8,859 | 1,280,185 | SH | SOLE | 1,280,185 | 0 | 0 | ||
| INOGEN INC | COM | 45780L104 | 275,285 | 3,549,320 | SH | SOLE | 3,549,320 | 0 | 0 | ||
| INVUITY INC | COM | 46187J205 | 10,482 | 1,318,448 | SH | SOLE | 1,318,448 | 0 | 0 | ||
| IRHYTHM TECHNOLOGIES INC | COM | 450056106 | 76,119 | 2,024,448 | SH | SOLE | 2,024,448 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 22,664 | 2,901,927 | SH | SOLE | 2,901,927 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | 34,400 | 1,410,417 | SH | SOLE | 1,410,417 | 0 | 0 | ||
| NABRIVA THERAPEUTICS AG | COM | 62957M104 | 27,919 | 2,326,544 | SH | SOLE | 2,326,544 | 0 | 0 | ||
| OBSEVA SA | COM | H5861P103 | 31,689 | 3,044,093 | SH | SOLE | 3,044,093 | 0 | 0 | ||
| OPKO HEALTH INC | COM | 68375N103 | 2 | 259 | SH | SOLE | 259 | 0 | 0 | ||
| RA PHARMACEUTICALS INC | COM | 74933V108 | 43,252 | 2,031,562 | SH | SOLE | 2,031,562 | 0 | 0 | ||
| REATA PHARMACEUTICALS INC | CL A | 75615P103 | 76,280 | 3,367,763 | SH | SOLE | 3,367,763 | 0 | 0 | ||
| SPECTRANETICS CORP | COM | 84760C107 | 34,342 | 1,179,122 | SH | SOLE | 1,179,122 | 0 | 0 | ||
| WRIGHT MED GROUP N V | RIGHT 03/01/2019 | N96617126 | 7,072 | 4,622,032 | PRN | SOLE | 0 | 0 | 4,622,032 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 510 | 127,563 | SH | SOLE | 127,563 | 0 | 0 | ||